Share of generic drug costs in Medicare Part D gap in the U.S. 2016-2020
This statistic shows the projection of the distribution of cost-sharing for generic drugs in the Medicare Part D coverage gap in the United States from 2016 to 2020. In 2016, 42 percent of the cost of generic drugs is expected to be paid by CMS. Provisions of the Affordable Care Act mandate the gradual closure of the Medicare Part D coverage gap through pharmaceutical manufacturer discounts and CMS subsidies.
